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Antibiotic prescribing should be appropriate and restricted,
since inappropriate use may contribute to the emergence of
resistant micro-organisms [1,2], may lead to unnecessary adverse
drug events [3,4], and has been associated with increased health
care costs [5]. As a guidance for appropriate choices of anti-
biotics, formularies have been developed. Antibiotic for-
mularies were used by 78% of 109 Dutch hospitals in 1991 [6],
and by 79% of British hospitals responding to a nationwide
questionnaire in 1990 [7]. These formularies are used as guide-
lines and the recommendations are not compulsory. Little is
known about practices of antibiotic prescription on general
hospital wards. In particular, indications for therapy and the
importance of the presence of objective criteria of infection
have seldom been studied. We therefore prospectively inves-
tigated antibiotic prescribing and indications for prescription in
three general internal medicine wards in a Dutch university
hospital.
Systemic and oral antibiotic prescribing was monitored pro-
spectively in three general internal medicine wards (69 beds) in
the University Hospital Maastricht in the Netherlands between
June 1996 and December 1996. Patients with HIV infection,
or kidney or bone marrow transplantation were excluded
because of specific protocol regimens. Demographic charac-
teristics, reason for admission, coexisting illnesses, and duration
of hospitalization were registered for all patients admitted. For
patients who received antibiotics the following additional data
were registered: types and dosages of antibiotics, indication for
prescription, duration of therapy and route of administration.
All microbiological investigations were monitored. Further-
more, relevant radiographic and laboratory results were
recorded. The following definitions were employed.
Infection episode and antibiotic episode: an episode of infec-
tion was defined as a documented or suspected episode of
infection for which antibiotic therapy was started. An episode
of antibiotic use was defined as the individual time span use of
prescription of one or more antibiotics for the treatment of an
infection episode (adjustment of therapy was not considered a
new episode).
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Microbiological evaluation: this included microbiological
cultures and Gram-stained smears obtained from patients
receiving antibiotics.
Antibiotic use: antibiotic use was expressed as the number of
episodes per patient and the number of antibiotic-days (i.e. the
total number of days that antibiotics were prescribed divided
by the total number of patient days).
Site of infection: five groups of infections were distinguished:
respiratory tract infections (RTI), urinary tract infections (UTI),
abdominal infections (cholangitis, peritonitis, pancreatitis and
gastro-enteritis), infections of skin and soft tissues, and a mis-
cellaneous group (bacteraemia, catheter-related infections and
fever of unknown origin).
Community- and hospital-acquired infection: an episode of
infection was considered community-acquired when infection
was presumed and antibiotic therapy was started within 48 h
after admission. Infections occurring after this time point were
considered community-acquired.
Adjustment of therapy: this was defined as streamlining or
changing antibiotic therapy based on the in vitro susceptibility
results of microbiological analysis (i.e. the bacteria isolated were
resistant to the empirical therapy).
Point scoring system: a point-scoring system was used to
objectively determine the presence of positive parameters of
infection in case of RTI or UTI episodes. The point-scoring
system included blood leukocytosis (one point) and left shift
(one point). Moreover, for RTI the presence of infiltrative
abnormalities on chest X-ray (one point), growth of micro-
organisms in sputum culture (one point), positive blood culture
compatible with RTI (one point), the presence of more than
10 leukocytes per high-power field in a sputum Gram stain
(one point) were included. For UTI, the presence of a positive
urine culture (one point), positive blood culture compatible
with UTI (one point), and the presence of bacteria or leu-
kocytes in urinary sedimentation (pyuria and/or bacteruria)
(one point) were included. The maximum scores were 6 and 5
for RTI and UTI, respectively.
In all, 435 patients (205 male, 230 female) with a mean age
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of 64 (219) years, and a mean duration of hospital stay of 13
(212) days and a total of 5422 patient-days were studied.
Thirty per cent (n = 130) of the population had coexisting
cardiovascular disease (hypertension not included), 14%
(n = 59) had hypertension, and 18% (n = 79) had diabetes melli-
tus. Hospital mortality was 5%, and 11 patients (3%) were finally
discharged to a nursing home. Fifty-four patients (12%) were
transferred to other departments within the hospital, mostly
(99%) to surgery.
Twenty-nine per cent (n = 126) of all patients received 132
episodes of antibiotics (Table 1). One hundred and twenty pat-
ients received one episode and six patients two episodes. The
number of antibiotic-days was 1129 representing 21% of all
5422 patient-days. Thirty-seven episodes were RTI, 35 were
UTI, 23 were abdominal infections, 17 were skin and soft tissue
infections, 20 belonged to the miscellaneous group. In most
episodes (n = 90, 68%) one antibiotic was prescribed, and in 41
(31%) episodes, combinations of two antibiotics were
Table 1 Number of episodes of antibiotic use according to indications for prescription
Respiratory Urinary Abdominal Skin & soft Miscellaneous
tract infection tract infection infections tissues infections infections
n = 37 n = 35 n = 23 n = 17 n = 20
b-lactam antibiotics
Penicillin 2
Amoxicillin 11 7 1 1 3
Amoxicillin + 24 18 9 7 9
Clavulanic acid
Flucloxacillin 2 4 3
Piperacillin 1 2 13 3
Ticarcillin + 1
Clavulanic acid
Cefuroxime 1 1 1
Ceftazidime 1 2 5
Aminoglycosides
Gentamicin 6 6 14 2 5
Amikacin 1
Macrolides
Erythromycin 2 1
Clarithromycin 2
Quinolones
Norfloxacin 11 1
Ofloxacin 3 1
Ciprofloxacin 4 2 2 1
Others
Co-trimoxazole 1 2
Clindamycin 5
Metronidazole 3 2
Tinidazol 1
Diloxanid 1
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prescribed. A combination of three antibiotics was prescribed
once. Initial therapy was parenteral in 93 episodes (70%) and a
switch to oral antibiotics occurred 18 times (19%). Patients
receiving antibiotics were older than patients not receiving
antibiotics, 69 (219) years versus 61 (218) years (P  0.001,
t-test), and had a longer hospital stay, 17 (217) days versus 10
(27) days (P  0.001, t-test).
Microbiological evaluation was performed in 116 (88%) of
132 therapeutic episodes and the clinical suspicion of infection
was microbiologically confirmed in 71 (61%) episodes.
Twenty-nine (78%) of 37 episodes of RTI were considered
to be community-acquired and 20 (69%) of these episodes
remained without microbiological documentation. In the
remaining nine patients Staphylococcus aureus was isolated from
sputum (once together with Haemophilus influenzae) in five, but
the clinical severity of infection did not correspond to the
expected severity of S. aureus pneumonia. Micro-organisms
typically associated with community-acquired RTI, such as H.
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influenzae, were isolated from only two patients, and no cultures
were positive for Streptococcus pneumoniae. The incidence of
hospital-acquired RTI was 2% (eight episodes among 435 pat-
ients), and only two of these episodes were microbiologically
confirmed. In summary, 70% (n = 26) of episodes of RTI were
not microbiologically confirmed. In addition, the point scores
for RTI episodes were low: being zero in five episodes, and
only one or two in 22 episodes (Figure 1). The combination of
blood leukocytosis and infiltrative abnormalities on chest X-
ray was present in eight cases, and infiltrative abnormalities only
were seen in 10 patients. Moreover, three of six episodes of
hospital-acquired RTI that were not confirmed by micro-
biological results had a point score of zero.
Initial therapy was administered intravenously in 30 episodes
(81%) and a switch to oral therapy occurred nine times (30%),
after a mean of 4 days. Adjustment of empirical treatment
occurred in six episodes. Based on in vitro susceptibilities, anti-
biotic spectra were narrowed four times. In one case, a micro-
organism associated with infection was resistant to empirical
treatment, and in another patient treatment was changed
because of clinical deterioration. Antibiotics were discontinued
during hospital stay in 17 episodes (46%) of RTI (after a mean
of 9 days), and 20 patients were receiving antibiotics (for a
mean of 8 days) until the day of discharge (13 parenteral and
seven orally).
Twenty-six (74%) of 35 episodes of UTI were community-
acquired. There were nine episodes of nosocomial UTI, cor-
responding to an incidence of nosocomial UTI of 2%. In con-
trast to RTI, the majority of UTI (n = 29, 83%) were
microbiologically confirmed. Escherichia coli was isolated in 13
(45%) of 29 episodes. However, 10 positive cultures (29%) were
obtained from patients having indwelling catheters.
As for RTI, the point scores for urinary tract infections were
low; 18 episodes (51%) had a point score 2 (Figure 1). In
addition to the 29 episodes with positive urine cultures, bacteria
or leukocytes were present in urinary sedimentation (pyuria
and/or bacteruria) in 32 episodes, and blood leukocytosis was
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Figure 1 Point scores for episodes of respiratory and urinary tract
infections.
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present in 21 episodes. Positive blood cultures, however, were
found in only six episodes (four of them with Escherichia coli).
Most episodes of UTI (80%, n = 28) were treated with one
antibiotic and a combination of two antibiotics was prescribed
in seven episodes. Thirteen episodes (37%) of UTI were initially
treated parenterally, and a switch to oral therapy occurred twice
(15%). Adjustment of empirical treatment occurred during 11
episodes; antibiotic spectra were narrowed in eight episodes,
one isolated pathogen was resistant to empirical therapy, and
antibiotics were blindly changed in one episode because of
persisting complaints of UTI. In one episode the antibiotic was
changed because of an adverse drug event. Fifteen patients
(43%) were still receiving antibiotics on the day of discharge
(nine orally and six parenterally), for a mean of 8 days. Anti-
biotics were discontinued during hospital stay in 20 episodes
(57%) of UTI (after a mean of 8 days).
The findings for other infections were comparable to those
made for RTI and UTI. In approximately 50% of all therapeutic
episodes no micro-organisms were isolated, and the proportions
of episodes that were initially treated parenterally ranged from
82% for skin and soft tissue infections to 96% for abdominal
infections.
In all, there were 211 antibiotic prescriptions (Table 1).
Amoxicillin-clavulanic acid was prescribed in 24 of 37 episodes
of RTI, in 18 of 35 episodes of UTI, and was the most fre-
quently used agent for skin and soft tissue infections. Inter-
estingly, although amoxicillin-clavulanic acid is recommended
for the treatment of community-acquired and nosocomial res-
piratory tract infections, urinary tract infections, abdominal
infections and skin and soft tissues infections in the antibiotic
formulary of our hospital, it is not the agent of first choice for
any of these infections. All episodes of clinical suspicion of
cholangitis were treated with the combination: piperacillin and
gentamicin.
The present survey on antibiotic use on general internal
medicine wards, under the circumstances tested, provides three
characteristics of antibiotic prescribing: (1) in the majority of
cases empirical antibiotic prescription was based on a clinical
suspicion of infection without objective criteria of infection;
(2) almost all antibiotics were initially administered parenterally
and a switch to oral medication seldom occurred, (3) irres-
pective of the site of infection and the most likely pathogen to
be causing that infection, a single broad-spectrum antibiotic,
usually amoxicillin-clavulanic acid, was prescribed. The trend
that emerges from our observations, is that antibiotic use is
nonrestrictive, and not always characterized by a wide variation
in antibiotics used. On the other hand, simultaneous use of
more than two antibiotics occurred only once, cephalosporins
were hardly used and there still is no problem of antibiotic
resistance, not even for amoxicillin-clavulanic acid, in our hos-
pital (data not shown).
Our results are consistent with the findings reported by
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Gyssens and coworkers [8]. They found, in two study periods,
that microbiological analysis was performed in 76–83% of all
episodes of antibiotic prescription and that relevant micro-
organisms were isolated in 59–69% of these cases. In that study
30% of all patients admitted to general medicine wards were
treated for infections, which is similar to 29% of the patients
that received antibiotics in the present study. Moreover, in a
British hospital in 1978, microbiological tests were carried out
in 67% of all episodes of infection and relevant bacteria were
isolated in 47% [9].
Our data, confirming observations reported by Gyssens and
Moss [8,9], suggest that in general medicine wards micro-
biological documentation of infection occurs in approximately
50% of all episodes, and that most of these patients will have
been treated empirically before culture results are available.
This situation is comparable to the problems with regard to
antimicrobial treatment of community-acquired pneumonia.
Even when applying a protocol of extensive microbiological
and serological analysis, causative agents of community-
acquired pneumonia remain undetermined in 50% of all cases
[10]. These observations emphasize the importance of empirical
treatment, and the potential values of antibiotic formularies.
Such antibiotic formularies were used by 78% of 109 Dutch
hospitals in 1991 [6], and by 79% of British hospitals responding
to a nation-wide questionnaire in 1990 [7]. The formularies are
used as guidelines and the recommendations are not compul-
sory. Moreover, guidelines for antibiotic prescription usually
are not very specific and may, as in our experience, stimulate
the use of a single antibiotic to treat a variety of infections. For
example, in the antibiotic formulary of our hospital, amoxi-
cillin-clavulanic acid is, among others, recommended for the
treatment of community-acquired and nosocomial respiratory
tract infections, urinary tract infections, abdominal infections
and skin and soft tissues infections, although amoxicillin-cla-
vulanic acid is not the agent of first choice for any of these
infections. Our data show that amoxicillin-clavulanic acid was
the initial choice of antibiotics for the majority of infections,
even at different anatomic sites of putative infection, where
different pathogens were to be expected. Almost all antibiotics
were prescribed parenterally, despite the fact that most patients
had no signs of malabsorption and were receiving other oral
medications at the same time. A switch to oral medication
occurred very seldom. There is emerging evidence that intra-
venous therapy can safely be switched to oral medication after
several days of treatment [11,12]. Adjustment from broad-spec-
trum to narrow-spectrum treatment occurred infrequently,
probably because pathogens responsible for presumed infections
were isolated infrequently. The latter may be related to the
scarcity of objective criteria of infection that were present,
suggesting that the threshold for physicians to start treatment
was low. However, our survey was not designed to specifically
judge the clinical validity of antibiotic prescriptions.
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Our finding that older patients received antibiotics more
frequently than younger patients is not new [9,10]. Considering
the increasing proportion of elderly patients, the higher risk of
adverse events of antibiotics in this population and the fact
that typical manifestations of infections may be absent in these
patients [13], provide a challenge for the future appropriate
antibiotic use in the elderly population.
Several strategies have been proposed to facilitate and
improve appropriate antibiotic use [14]. Establishing an appro-
priate and restrictive practice of antibiotic use should become
a high priority of clinical medicine. The findings of the present
and other surveys of antibiotic prescribing in general medicine
wards, suggest that there is wide difference between the defined
principles of antibiotic policies and the clinical use of anti-
microbial agents.
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